These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1409443)

  • 21. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosinase activity (TH, DO, PAGE-defined isozymes) and melanin production in regenerating hairbulb melanocytes of lethal yellow (Ay/a), black (a/a), agouti (AwJ/AwJ/) and albino (a/a/c2J/c2J) mice (C57BL/6J).
    Granholm NH; Opbroek AJ; Harvison GA; Kappenman KE
    Pigment Cell Res; 1990 Nov; 3(5):233-42. PubMed ID: 2128897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism.
    Giménez E; Lavado A; Giraldo P; Cozar P; Jeffery G; Montoliu L
    Pigment Cell Res; 2004 Aug; 17(4):363-70. PubMed ID: 15250938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression.
    Ni-Komatsu L; Orlow SJ
    Exp Eye Res; 2006 Mar; 82(3):519-28. PubMed ID: 16199032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: correction by culture in the presence of excess tyrosine.
    Rosemblat S; Sviderskaya EV; Easty DJ; Wilson A; Kwon BS; Bennett DC; Orlow SJ
    Exp Cell Res; 1998 Mar; 239(2):344-52. PubMed ID: 9521852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopa reaction test in hair bulbs of fetuses and its application to the prenatal diagnosis of albinism.
    Gershoni-Baruch R; Benderly A; Brandes JM; Gilhar A
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):220-2. PubMed ID: 1901069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
    Oetting WS; Fryer JP; King RA
    Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
    [No Abstract]   [Full Text] [Related]  

  • 30. Tyrp1 and oculocutaneous albinism type 3.
    Sarangarajan R; Boissy RE
    Pigment Cell Res; 2001 Dec; 14(6):437-44. PubMed ID: 11775055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity.
    Hearing VJ; Ekel TM; Montague PM; Hearing ED; Nicholson JM
    Arch Biochem Biophys; 1978 Jan; 185(2):407-18. PubMed ID: 415664
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic basis of pigmentation and its disorders.
    Klein LE; Nordlund JJ
    Int J Dermatol; 1981 Dec; 20(10):621-31. PubMed ID: 6799413
    [No Abstract]   [Full Text] [Related]  

  • 33. Misrouting of tyrosinase with a truncated cytoplasmic tail as a result of the murine platinum (cp) mutation.
    Beermann F; Orlow SJ; Boissy RE; Schmidt A; Boissy YL; Lamoreux ML
    Exp Eye Res; 1995 Nov; 61(5):599-607. PubMed ID: 8654502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
    Shimizu H
    Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progresses in understanding pigmentation.
    Kosmadaki MG; Naif A; Hee-Young P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):47-55. PubMed ID: 20197745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammalin tyrosinase. Stoichiometry and measurement of reaction products.
    Hearing VJ; Ekel TM; Montague PM; Nicholson JM
    Biochim Biophys Acta; 1980 Feb; 611(2):251-68. PubMed ID: 6766744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA; Oetting WS
    Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms governing melanogenesis in hamster melanomas: relative abundance of tyrosinase and catalase-B (gp 75).
    Slominski A; Costantino R; Howe J; Moellmann G
    Anticancer Res; 1991; 11(1):257-62. PubMed ID: 1673330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. l-tyrosine induces melanocyte differentiation in novel pink-eyed dilution castaneus mouse mutant showing age-related pigmentation.
    Hirobe T; Ishikawa A
    J Dermatol Sci; 2015 Dec; 80(3):203-11. PubMed ID: 26475433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New regulators of melanogenesis are associated with purified tyrosinase isozymes.
    Hearing VJ; Korner AM; Pawelek JM
    J Invest Dermatol; 1982 Jul; 79(1):16-8. PubMed ID: 6806397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.